CN1060086C - Traditional Chinese medicine capsule for eliminating indurated goiter - Google Patents
Traditional Chinese medicine capsule for eliminating indurated goiter Download PDFInfo
- Publication number
- CN1060086C CN1060086C CN98107184A CN98107184A CN1060086C CN 1060086 C CN1060086 C CN 1060086C CN 98107184 A CN98107184 A CN 98107184A CN 98107184 A CN98107184 A CN 98107184A CN 1060086 C CN1060086 C CN 1060086C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- aspongopus
- eliminating
- shallow oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention belongs to the field of traditional Chinese medicine preparation product. The traditional Chinese medicine capsule comprises components with the proportion by weight: 8.5 to 9.5% of aspongopus, 8.5 to 9.5% of mume flower, 7 to 8% of earthworm, 7 to 8% of tokay gecko, 14 to 16% of pangolin scale, 10.5 to 11.8% of turtle shell, 4 to 5% of tamariskoid spikemoss herb, 4 to 5% of prepared olibanum, 4 to 5% of prepared myrrh, 10.5 to 11.8% of szechwan chinaberry fruit, 8 to 10% of rhizoma corydalis and 7 to 8% of ground beeltle. The medicines are made into granules and encapsulated after being infused and dried. The traditional Chinese medicine capsule has the efficiency of activating blood circulation to dissipate blood stasis, softening and resolving hard mass, eliminating stones and relieving pain, and has obvious therapeutic effect on diseases of cholecystitis, gallstone, urinary calculus, thyroid enlargement, prostatomegaly, prostatitis, etc.
Description
The invention belongs to the Chinese medicine product field.
Existing treatment cholelithiasis Chinese patent medicine kind is a lot, but in use effect is not ideal mostly, and some medicine commonly used such as the intestines and stomach have stimulation, and pharmaceutical compositions has harmful effect to heart disease, myasthenia gravis etc., and side effect is bigger.Patent Office of the People's Republic of China's on August 27th, 97, disclosed " liver and gall litholytic capsule " (publication number CN1157726A) introduced a kind of treatment liver and bile stone medicine; prescription is: Herba clerodendranthi spicati, Endothelium corneum Anas domestica, Spora Lygodii, yellow young powder, Squama Manis, succinum, Rhizoma Curcumae Longae, Radix Et Rhizoma Rhei, Radix Curcumae, Calculus Bovis, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae etc.; has depressed liver-energy dispersing and function of gallbladder promoting; removing damp-heat, the effect of softening the hard mass calculi dissolving.But it is comparatively single that this medication is imitated, effective to cholelithiasis, and urinary system calculus and prostatauxe, thyromegaly are not almost had effect.
The objective of the invention is weak point not satisfactory at the curative effect of medication of existing treatment calculus or that therapeutic domain is narrow, a kind of treatment plurality of calculi disease and thyroid, prostatitis are provided, the significant Chinese medicinal capsule of therapeutic effect.
Technical scheme of the present invention is such: each raw material weight ratio of this Chinese medicinal capsule is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.
The present invention has following advantage:
1. this Chinese medicinal capsule has the effect of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, Sal Nitri analgesic therapy, and diseases such as cholecystitis, cholelithiasis, urinary system calculus, thyromegaly, prostate hyperplasia, prostatitis are all had significant curative effect.
2. the prescription of this Chinese medicinal capsule is formed all medicine uniquenesses, the side's of system principle is to set out with integral body, and from pathogenic mechanism, medicines such as conventional 'Shugan Lidan ' medicine, inducing diuresis for treating stranguria syndrome are almost useless, therapeutic effect gets instant result, and can reach the clinical cure purpose 2-3 courses of treatment of taking medicine.
Embodiments of the invention are as follows:
This medicine composition each component weight ratio is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.Each capsule explosive payload is 0.2g.
When taking every day secondary, each 2, one month is a course of treatment.
Claims (1)
1. the eliminating indurated goiter Chinese medicinal capsule is characterized in that each raw material weight ratio of this Chinese medicinal capsule is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98107184A CN1060086C (en) | 1998-04-11 | 1998-04-11 | Traditional Chinese medicine capsule for eliminating indurated goiter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98107184A CN1060086C (en) | 1998-04-11 | 1998-04-11 | Traditional Chinese medicine capsule for eliminating indurated goiter |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1194158A CN1194158A (en) | 1998-09-30 |
CN1060086C true CN1060086C (en) | 2001-01-03 |
Family
ID=5219259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98107184A Expired - Fee Related CN1060086C (en) | 1998-04-11 | 1998-04-11 | Traditional Chinese medicine capsule for eliminating indurated goiter |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1060086C (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1030641A (en) * | 1987-07-10 | 1989-01-25 | 浙江大学 | The Mei Er moire fringe testing method and the device thereof of minute surface flatness |
-
1998
- 1998-04-11 CN CN98107184A patent/CN1060086C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1030641A (en) * | 1987-07-10 | 1989-01-25 | 浙江大学 | The Mei Er moire fringe testing method and the device thereof of minute surface flatness |
Non-Patent Citations (3)
Title |
---|
《广西中医药》1993年第16卷第4期 1993.1.1 李士桂,公核饮 * |
《广西中医药》1993年第16卷第4期 1993.1.1 李士桂,公核饮;《湖南中医杂志》1986年第2卷第3期 1986.1.1 王敬璇,以化石丸为主治疗泌尿系统结石100例临床观察 * |
《湖南中医杂志》1986年第2卷第3期 1986.1.1 王敬璇,以化石丸为主治疗泌尿系统结石100例临床观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1194158A (en) | 1998-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
CN1101692C (en) | Method for preparing Chinese medicine for curing apoplexy and hemiparalysis | |
CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
CN100381146C (en) | Traditional Chinese medicine for treating rheumatism | |
CN101327305A (en) | Chinese medicine for treating appendicitis and preparation method thereof | |
CN110755517A (en) | Pain-relieving liquid | |
CN1059105C (en) | Bi Syndrome curing medicine | |
CN1071123C (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
CN1060086C (en) | Traditional Chinese medicine capsule for eliminating indurated goiter | |
CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
CN1283302C (en) | Medicament for treating rheumatoid arthritis and artjritis pauperum | |
CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
CN1129439C (en) | Hyperosteogeny-treating capsule | |
CN101284087B (en) | Medicinal composition for curing lumbar disease | |
CN102000286A (en) | Traditional Chinese medicine preparation for treating polyneuritis | |
CN101987128A (en) | Traditional Chinese medical preparation for treating urticaria | |
CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
CN100402077C (en) | Medicinal composition for treating hyperosteogency | |
CN1055006C (en) | Chinese medicine for curing thrombus, rheumatism and other diseases | |
CN1175875C (en) | Medicine made of lysimachia for treating hepatobiliary calculus and its prescription | |
CN115192689B (en) | Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain, application and traditional Chinese medicine preparation thereof | |
CN1163256C (en) | Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer radically | |
CN102028886A (en) | Chinese medicinal preparation for treating tetanus | |
CN102178883B (en) | Preparation method of traditional Chinese medicine for treating hunger type frostbite | |
CN1225269C (en) | Medicine for treating prospoalgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010103 Termination date: 20130411 |